Howe & Rusling’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History
Bought
Maintained
Sold
Other funds holding BTAL
FDCDDQ
TWM
APA
GIA
TI
T
KWM
Howe & Rusling's BTAL Position: Q1 2021 in Review
Howe & Rusling sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q1 2021, closing a stake of 802 shares — an estimated $15K sold.
Howe & Rusling first reported a position in BTAL in Q2 2020 and held it in 3 quarters. The position peaked at $15K in Q4 2020. 32 funds tracked by Wall St. Rank hold BTAL as of Q1 2021.
- Howe & Rusling reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q1 2021 after selling out during the quarter.
- Howe & Rusling sold 802 AGF US Market Neutral Anti-Beta Fund shares in Q1 2021, an estimated $15K.
- Howe & Rusling first reported a position in AGF US Market Neutral Anti-Beta Fund in Q2 2020 and held it in 3 quarters.
- Howe & Rusling's AGF US Market Neutral Anti-Beta Fund position peaked at $15K in Q4 2020.
- 32 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q1 2021.
Based on Howe & Rusling's 13F filing for Q1 2021, filed 13 May 2021.